SEC / FDA / FTC Regulatory Watch

SEC/FDA/FTC Regulatory Watch — Week of May 19–27, 2026

This week's key regulatory actions: the SEC settles the Adani bribery case and drops its 50-year 'no-deny' settlement policy; the FDA approves the first-ever hepatitis delta treatment and opens BHT/ADA food additive reviews; plus new SEC rule proposals that could end mandatory quarterly reporting.